Neovasc Inc (NVCN.OQ)
20 Apr 2018
Thu, Feb 1 2018
* NEOVASC ANNOUNCES RECEIPT OF GERMAN NUB STATUS 1 DESIGNATION FOR NEOVASC REDUCER™ PROCEDURE FOR TREATMENT OF REFRACTORY ANGINA Source text for Eikon: Further company coverage:
* FRED COLEN APPOINTED CHIEF EXECUTIVE OFFICER OF NEOVASC INC.
* CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING Source text : [http://bit.ly/2kZxgLY] Further company coverage:
* Neovasc Inc - Revenues decreased 55% to $1.4 million for three months ended September 30, 2017, compared to revenues of $3.0 million
* NEOVASC ANNOUNCES US$65 MILLION UNDERWRITTEN OFFERING OF UNITS CONSISTING OF COMMON SHARES AND WARRANTS TO PURCHASE COMMON SHARES AND CONCURRENT PRIVATE PLACEMENT OF NOTES AND WARRANTS
* Neovasc receives FDA approval to initiate pivotal reducer trial
* Says Court Of Appeals affirmed judgment of U.S. District Court for District of Massachusetts in case of Cardiaq Valve Tech versus co
- Neovasc's (NVCN) CEO Fred Colen on Q4 2017 Results - Earnings Call Transcript
- Neovasc's (NVCN) CEO Alexei Marko on Q3 2017 Results - Earnings Call Transcript
- Neovasc: When Management Is Fraudulent, You Are Toast
- Neovasc's (NVCN) CEO Alexei Marko on Q2 2017 Results - Earnings Call Transcript
- Neovasc's (NVCN) CEO Alexei Marko on Q1 2017 Results - Earnings Call Transcript
- Is This Investment Too Risky?